Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction: Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis ; volume:24 ; number:1 ; day:23 ; month:5 ; year:2022 ; pages:1 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (23.5.2022), 1, 12.2022
- Urheber
-
Rice, Lisa M.
Mantero, Julio C.
Stratton, Eric A.
Warburton, Rod
Roberts, Kari
Hill, Nicholas
Simms, Robert W.
Domsic, Robyn
Farber, Harrison W.
Lafyatis, Robert
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-022-02816-8
- URN
-
urn:nbn:de:101:1-2022072619070297071858
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rice, Lisa M.
- Mantero, Julio C.
- Stratton, Eric A.
- Warburton, Rod
- Roberts, Kari
- Hill, Nicholas
- Simms, Robert W.
- Domsic, Robyn
- Farber, Harrison W.
- Lafyatis, Robert
- SpringerLink (Online service)
Ähnliche Objekte (12)
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Pulmonary blood density in systemic sclerosis – a novel non-invasive measure of pulmonary arterial hypertension?
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Pulmonary blood density in systemic sclerosis – a novel non-invasive measure of pulmonary arterial hypertension?
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension
Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis
Variants of PBEF predispose to systemic sclerosis and pulmonary arterial hypertension development
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia
Relapsing polychondritis presenting 2 years after systemic sclerosis with pulmonary arterial hypertension
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension
Pulmonary blood density in systemic sclerosis – a novel non-invasive measure of pulmonary arterial hypertension?
Serum VEGF levels are related to the presence of pulmonary arterial hypertension in systemic sclerosis
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension